{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:34:58Z","timestamp":1792510498565,"version":"4.5.0"},"reference-count":42,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"unspecified","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Yunnan Fundamental Research Projects","award":["202401CF070053"],"award-info":[{"award-number":["202401CF070053"]}]},{"name":"Yunnan Fundamental Research Projects","award":["202501AT070103"],"award-info":[{"award-number":["202501AT070103"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304418"],"award-info":[{"award-number":["82304418"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373813"],"award-info":[{"award-number":["82373813"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82560700"],"award-info":[{"award-number":["82560700"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Innovative Research Team of Yunnan Province","award":["202405AS350016"],"award-info":[{"award-number":["202405AS350016"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,7,14]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chimeric antigen receptor (CAR) macrophage therapy shows significant potential for solid tumors owing to the intrinsic tumor infiltration and phagocytic capacity of macrophages. However, its clinical translation is limited by macrophage phenotypic plasticity within the immunosuppressive tumor microenvironment and the complexity of ex vivo cell manufacturing. It is essential to develop techniques that enable macrophages to be activated specifically by antigens while sustaining their proinflammatory activity in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Here, we report a mannose-modified lipid nanoparticle (LNP) platform for the co-delivery of CAR-encoding messenger RNA (mRNA) and the Toll-like receptor (TLR) 7\/8 agonist resiquimod (R848), enabling in situ generation of proinflammatory CAR macrophages. In vitro, we assessed macrophage-preferential uptake, CAR expression efficiency, TLR7\/8 agonist-mediated macrophage polarization, and immune activation. In vivo efficacy was assessed in syngeneic and humanized mouse models of triple-negative breast cancer, including postoperative recurrence and lung metastasis models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Systemic administration of M-LNP\/CAR+R848 induced robust CAR expression in tumor-associated macrophages and promoted sustained M1 polarization. Engineered macrophages exhibited enhanced antigen-specific phagocytic activity and tumor cell clearance, and promoted CD8+ T\u2009cell proliferation and NK cell infiltration, thus coordinating innate and adaptive immune responses. Functional macrophage depletion experiments demonstrated that tumor control was dependent on macrophages. In vivo treatment significantly reduced the growth of primary tumors, prevented postoperative recurrence, and prolonged survival in mice with lung metastases in both syngeneic and humanized models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings demonstrate that M-LNPs enabling co-delivery of mRNA and an innate immune agonist enable in situ generation of proinflammatory CAR macrophages and induce durable antitumor immunity. This controllable and non-integrative strategy allows tunable immune activation, provides a flexible platform for CAR macrophage-based immunotherapy in triple-negative breast cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2026-015323","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:25:21Z","timestamp":1785241521000},"page":"e015323","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["In situ generation of proinflammatory CAR macrophages via mRNA-TLR agonist co-delivery for triple-negative breast cancer immunotherapy"],"prefix":"10.1136","volume":"14","author":[{"given":"Jing-E","family":"Zhou","sequence":"first","affiliation":[{"name":"Key Laboratory of Breast Cancer Precision Medicine, School of Biomedical Engineering, Kunming Medical University, Kunming, Yunnan, China"},{"name":"School of Pharmacy, East China Normal University, Shanghai, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7491-0805","authenticated-orcid":false,"given":"Yiyan","family":"Hu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Breast Cancer Precision Medicine, School of Biomedical Engineering, Kunming Medical University, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Key Laboratory of Breast Cancer Precision Medicine, School of Biomedical Engineering, Kunming Medical University, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Liu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Breast Cancer Precision Medicine, School of Biomedical Engineering, Kunming Medical University, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Gao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Breast Cancer Precision Medicine, School of Biomedical Engineering, Kunming Medical University, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Dai","sequence":"additional","affiliation":[{"name":"Key Laboratory of Breast Cancer Precision Medicine, School of Biomedical Engineering, Kunming Medical University, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Breast Cancer Precision Medicine, School of Biomedical Engineering, Kunming Medical University, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yu","sequence":"additional","affiliation":[{"name":"Shanghai Unicar-Therapy Bio-medicine Technology, Shanghai, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Xu","sequence":"additional","affiliation":[{"name":"Shanghai Unicar-Therapy Bio-medicine Technology, Shanghai, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Basic Medicine, Sichuan Vocational College of Health and Rehabilitation, Zigong, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Yan","sequence":"additional","affiliation":[{"name":"School of Pharmacy, East China Normal University, Shanghai, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Sun","sequence":"additional","affiliation":[{"name":"School of Pharmacy, East China Normal University, Shanghai, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fubing","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Breast Cancer Precision Medicine, School of Biomedical Engineering, Kunming Medical University, Kunming, Yunnan, China"},{"name":"Department of Basic Medicine, Sichuan Vocational College of Health and Rehabilitation, Zigong, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6398-3516","authenticated-orcid":false,"given":"Ceshi","family":"Chen","sequence":"additional","affiliation":[{"name":"Key Laboratory of Breast Cancer Precision Medicine, School of Biomedical Engineering, Kunming Medical University, Kunming, Yunnan, China"},{"name":"The Third Affiliated Hospital, Kunming Medical University, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"2026072805251765000_14.7.e015323.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.07.002"},{"key":"2026072805251765000_14.7.e015323.2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0817-691"},{"key":"2026072805251765000_14.7.e015323.3","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85309"},{"key":"2026072805251765000_14.7.e015323.4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-062315-120245"},{"key":"2026072805251765000_14.7.e015323.5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.566511","article-title":"Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers","volume":"10","author":"Larionova","year":"2020","journal-title":"Front Oncol"},{"key":"2026072805251765000_14.7.e015323.6","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01328-x","article-title":"Targeting macrophages in hematological malignancies: recent advances and future directions","volume":"15","author":"Li","year":"2022","journal-title":"J Hematol Oncol"},{"key":"2026072805251765000_14.7.e015323.7","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1021\/acsabm.0c00368","article-title":"Targeted Imaging of CD206 Expressing Tumor-Associated M2-like Macrophages Using Mannose-Conjugated Antibiofouling Magnetic Iron Oxide Nanoparticles","volume":"3","author":"Li","year":"2020","journal-title":"ACS Appl Bio Mater"},{"key":"2026072805251765000_14.7.e015323.8","doi-asserted-by":"crossref","DOI":"10.12703\/P6-13","article-title":"The M1 and M2 paradigm of macrophage activation: time for reassessment","volume":"6","author":"Martinez","year":"2014","journal-title":"F1000Prime Rep"},{"key":"2026072805251765000_14.7.e015323.9","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202410340","article-title":"Engineered Nanoparticles for Enhanced Antitumoral Synergy Between Macrophages and T Cells in the Tumor Microenvironment","volume":"36","author":"Moon","year":"2024","journal-title":"Adv Mater"},{"key":"2026072805251765000_14.7.e015323.10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn1128","article-title":"Intracavity generation of glioma stem cell-specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy","volume":"14","author":"Chen","year":"2022","journal-title":"Sci Transl Med"},{"key":"2026072805251765000_14.7.e015323.11","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s43018-025-00950-1","article-title":"An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma","volume":"6","author":"Jing","year":"2025","journal-title":"Nat Cancer"},{"key":"2026072805251765000_14.7.e015323.12","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101805","article-title":"In situ MUC1-specific CAR engineering of tumor-supportive macrophages stimulates tumoricidal immunity against pancreatic adenocarcinoma","volume":"49","author":"Liu","year":"2023","journal-title":"Nano Today"},{"key":"2026072805251765000_14.7.e015323.13","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c10109"},{"key":"2026072805251765000_14.7.e015323.14","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1039\/D5NR03762J","article-title":"In situ programming of CAR-macrophages via a polyplex nanomaterial and STING activation for triple-negative breast cancer immunotherapy","volume":"18","author":"Siddiqui","year":"2026","journal-title":"Nanoscale"},{"key":"2026072805251765000_14.7.e015323.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.03.014"},{"key":"2026072805251765000_14.7.e015323.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.06.017"},{"key":"2026072805251765000_14.7.e015323.17","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12527"},{"key":"2026072805251765000_14.7.e015323.18","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2020.05.009"},{"key":"2026072805251765000_14.7.e015323.19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1121623109"},{"key":"2026072805251765000_14.7.e015323.20","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/j.apsb.2025.03.039","article-title":"CDH17-targeting CAR-NK cells synergize with CD47 blockade for potent suppression of gastrointestinal cancers","volume":"15","author":"Zheng","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"2026072805251765000_14.7.e015323.21","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu025"},{"key":"2026072805251765000_14.7.e015323.22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1227833","article-title":"Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy","volume":"14","author":"Chakraborty","year":"2023","journal-title":"Front Immunol"},{"key":"2026072805251765000_14.7.e015323.23","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11091503","article-title":"ProLonged Liposomal Delivery of TLR7\/8 Agonist for Enhanced Cancer Vaccine","volume":"11","author":"Kim","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"2026072805251765000_14.7.e015323.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0390-x"},{"key":"2026072805251765000_14.7.e015323.25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2019.10.020","article-title":"TLR 7\/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages","volume":"469","author":"Liu","year":"2020","journal-title":"Cancer Lett"},{"key":"2026072805251765000_14.7.e015323.26","doi-asserted-by":"crossref","unstructured":"Malik V , Ramesh A , Kulkarni AA . TLR7\/8 Agonist and SHP2 Inhibitor Loaded Nanoparticle Enhances Macrophage Immunotherapy Efficacy. Advanced Therapeutics 2021;4. doi:10.1002\/adtp.202100086","DOI":"10.1002\/adtp.202100086"},{"key":"2026072805251765000_14.7.e015323.27","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.1021\/acs.nanolett.1c01968","article-title":"Lymph-Node-Targeted Cholesterolized TLR7 Agonist Liposomes Provoke a Safe and Durable Antitumor Response","volume":"21","author":"Wan","year":"2021","journal-title":"Nano Lett"},{"key":"2026072805251765000_14.7.e015323.28","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19486-2","article-title":"In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo","volume":"11","author":"Parayath","year":"2020","journal-title":"Nat Commun"},{"key":"2026072805251765000_14.7.e015323.29","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"2026072805251765000_14.7.e015323.30","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-025-02512-4","article-title":"Scarless circular mRNA-based CAR-T cell therapy elicits superior antitumor efficacy","volume":"10","author":"Hu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"2026072805251765000_14.7.e015323.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2023.08.005"},{"key":"2026072805251765000_14.7.e015323.32","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101139","article-title":"Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering","volume":"31","author":"Kitte","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2026072805251765000_14.7.e015323.33","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202310395","article-title":"Spleen SORT LNP Generated in situ CAR T Cells Extend Survival in a Mouse Model of Lymphoreplete B Cell Lymphoma","volume":"62","author":"\u00c1lvarez-Benedicto","year":"2023","journal-title":"Angew Chem Int Ed Engl"},{"key":"2026072805251765000_14.7.e015323.34","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202409812","article-title":"Simplified Lipid Nanoparticles for Tissue- And Cell-Targeted mRNA Delivery Facilitate Precision Tumor Therapy in a Lung Metastasis Mouse Model","volume":"36","author":"Fei","year":"2024","journal-title":"Adv Mater"},{"key":"2026072805251765000_14.7.e015323.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00811-9"},{"key":"2026072805251765000_14.7.e015323.36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41587-025-02556-5","article-title":"Safer non-viral DNA delivery using lipid nanoparticles loaded with endogenous anti-inflammatory lipids","volume":"44","author":"Patel","year":"2026","journal-title":"Nat Biotechnol"},{"key":"2026072805251765000_14.7.e015323.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.07.021"},{"key":"2026072805251765000_14.7.e015323.38","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113328","article-title":"Trop2: Jack of All Trades, Master of None","volume":"12","author":"Len\u00e1rt","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026072805251765000_14.7.e015323.39","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.36"},{"key":"2026072805251765000_14.7.e015323.40","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-3119"},{"key":"2026072805251765000_14.7.e015323.41","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-67674-9","article-title":"Intraperitoneal programming of tailored CAR macrophages via mRNA lipid nanoparticle to boost cancer immunotherapy","volume":"17","author":"Gu","year":"2025","journal-title":"Nat Commun"},{"key":"2026072805251765000_14.7.e015323.42","doi-asserted-by":"crossref","unstructured":"Wang Y , Zuo S , Bao H , et al . Pooled screening identifies combinatorial car signaling domains for next-generation car-m immunotherapies. Bioengineering [Preprint] 2025. doi:10.1101\/2025.02.16.638489","DOI":"10.1101\/2025.02.16.638489"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2026-015323","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:25:24Z","timestamp":1785241524000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2026-015323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,28]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/jitc-2026-015323"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2026-015323","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}